Arc Bio Team

Executive Team

Todd Dickinson

Todd Dickinson

Chief Executive Officer

Todd Dickinson has been the CEO of Arc Bio and Dovetail Genomics since February 2015. He is a founding scientist of Illumina and has held numerous technical and commercial executive roles both at Illumina and subsequently at BioNano Genomics.

David Pryor, MD

David Pryor, MD

Chief Medical Officer

David Pryor is the Chief Medical Officer providing overall senior clinical leadership. He joined the leadership team in 2020 having served on the scientific advisory board since 2017. David has over 35 years’ experience as a distinguished health care leader, most recently as the former Executive VP and Chief Clinical Officer of Ascension Health. He has served on many national and international committees, authored over 250 publications, and has been recognized as being among the most influential leaders and physicians in health care.

Naissan Hussainzada

Naissan Hussainzada

Vice President, Commercial Operations

Naissan Hussainzada has >15 years of experience in the pharmaceutical and biotech industry experience across therapeutic sectors including CNS disorders, GI disorders, infectious disease, clinical toxicology and molecular diagnostics.

Matt Easterday

Matt Easterday

General Counsel

 Matt Easterday is the General Counsel for Dovetail and EdenRoc Sciences LLC. Matt has a PhD in neuroscience from UCLA and a J.D. from Univ Minnesota. He has worked extensively with early stage companies in the life sciences.

Co-Founders

Carlos Bustamante

Carlos Bustamante

Co-Founder

 Professor Carlos Bustamante is an internationally recognized leader in data science and genomics technologies. He is currently Professor of Biomedical Data Science, Genetics and Biology at Stanford University.

David Sinclair

David Sinclair

Co-Founder

 Professor David Sinclair is at the department of Genetics and co-Director of the Paul Glenn Center for the Biology of Aging at Harvard Medical School. Time magazine recently named him on their list ”100 most influential people in the world”.

Leadership Team

Meredith Carpenter

Meredith Carpenter

Director, Assay Development

 Meredith Carpenter has been with Arc Bio since its inception. She has a PhD in Molecular and Cell Biology from UC Berkeley and post-doc at Stanford. Broad expertise in ancient DNA, forensics, and clinical sample methods development.

Gavin Wall

Gavin Wall

Director, Clinical Deployment

 Gavin Wall is a clinical microbiologist with 17 years of international experience in both clinical microbiology laboratories and the in vitro diagnostic devices industry. Former lead of Medical Affairs, Infectious Diseases for Qiagen.

Thomas Watson

Thomas Watson

Director, Informatics

 Thomas Watson has been with Arc Bio since its inception. He has a PhD in Quantum Chemistry from the University of Florida and completed post-doctoral work at Princeton. Expertise spanning all areas of computational biology.

Scientific Advisory Board

David Relman, MD

David Relman, MD

Thomas C. and Joan M. Merigan Professor in Medicine, and Microbiology & Immunology, and Co-Director of the Center for International Security and Cooperation at Stanford University

 

He is also Chief of Infectious Diseases at the Veterans Affairs Palo Alto Health Care System in Palo Alto, California. Dr. Relman’s research focus is the human indigenous microbiota, and the identification of previously-unrecognized microbial agents of disease. He has advised the U.S. Government on emerging infectious diseases, human-microbe interactions, and future biological threats.

Ami Bhatt, MD, PhD

Ami Bhatt, MD, PhD

Assistant Professor of Medicine (Hematology) and Genetics at Stanford University

 

Dr. Bhatt’s group works to identify problems and questions that arise in the course of routine clinical care through the use of modern genetic, molecular and computational techniques. She seeks to exhaustively characterize the dynamics of the microbiota and environmental pathogens in immunocompromised and underserved populations and to explore how changes in the microbiome are associated with diseases in these populations.

Beth Shapiro, PhD

Beth Shapiro, PhD

Associate Professor in the Department of Ecology & Evolutionary Biology at UC Santa Cruz

 

She was also selected as a MacArthur fellow in 2009. Dr. Shapiro’s research aims to better understand how populations and species change through time, particularly in response to environmental and other changes to their habitat using the latest experimental and computational approaches to analyze genetic information isolated from fossil and archived remains.

Chris Mason, PhD

Chris Mason, PhD

Associate Professor at Weill Cornell Medicine

 

He also has appointments at the Tri-Institutional Program in Computational Biology and Medicine between Cornell, Memorial Sloan-Kettering Cancer Center and Rockefeller University, the Sandra and Edward Meyer Cancer Center, and the Feil Family Brain and Mind Research Institute. His lab develops and deploys new biochemical and computational methods in functional genomics to elucidate the genetic basis of human disease and human physiology.  

Dan Rokshar, PhD

Dan Rokshar, PhD

Professor of Genetics, Genomics and Development at the University of California at Berkley

 

Dr. Rokhsar’s research is focused on understanding the origin, evolution, and diversity of animals (and, more generally, other groups of eukaryotes) by combining computational genome analysis with comparative developmental biology. He is a specialist in de novo genome assembly.

Richard "Ed" Green, PhD

Richard "Ed" Green, PhD

Assistant Professor in the Department of Biomolecular Engineering at UC Santa Cruz

 

He led the project to sequence the first Neandertal genome in 2008, and he has extensive expertise in genomics and computational molecular biology. He is also President of Dovetail Genomics, a company that is commercializing Dr. Green’s work developing an in vitro method for constructing mate-pair libraries whose inserts span all distances up to the size of the input DNA.

Yaniv Erlich, PhD

Yaniv Erlich, PhD

Assistant Professor of Computer Science and Computational Biology at Columbia University

 

He is also a core member at the New York Genome Center and is currently CSO of MyHeritage. Dr. Erlich’s research interests revolve around computational human genetics.

Bob Kain

Bob Kain

 

An avid inventor experienced R&D leader, a biotech executive, entrepreneur, and active member of his community. Bob retired from Illumina in 2014 after 14 years as Chief Engineering Officer. Prior to joining Illumina, Bob was the Director of the Microarray Business Unit at Molecular Dynamics.